We need additional transparency to inform our policies.
The price of STELARA in the U.S. is $79,000 a year.
I think we need more transparency. And I think we need more transparency to inform the policies that we adopt.
Let's look at, Mr. Boerner, the price of ELIQUIS is--in the U.S. has increased by $4,000 since its launch.
I was pleased this last May that this Committee advanced my bipartisan Fair Drug Pricing Act, which I lead with Senator ...
even one veteran suicide is too many, and I know you are working to reduce this troubling epidemic.
That 67 percent decline in prescription rates over the last decade is extraordinary and is really a testament to the pro...